文献速递胃肠外科急腹症与外科感染

抗反流与食管裂孔疝手术后30天和90天按Clavien-Dindo分级统计的发病率与死亡率

Thirty- and 90-Day Morbidity and Mortality by Clavien-Dindo after Surgery for Antireflux and Hiatal Hernia.
PubMed 文献 · J Am Coll Surg · 2024-09-16

该研究回顾性分析2003年至2020年单中心2342例抗反流与食管裂孔疝手术病例,按Clavien-Dindo分级评估术后30天和31至90天并发症与死亡。30天总发病率18.2%、死亡率0.2%,多数为CD<3a的轻微并发症(13.1%);31至90天发病率降至3.1%、死亡率0.09%,CD<3a为1.9%。作者认为此类手术安全,死亡罕见,多数并发症轻微且易处理,少数需额外干预。

要点

  • 30天总发病率18.2%(427/2342),死亡率0.2%(4/2342),CD<3a并发症占13.1%(306/2342)。
  • 31至90天发病率降至3.1%(78/2338),死亡率0.09%(2/2338),CD<3a为1.9%(42/2338)。
  • 多数并发症为轻微(CD<3a)且易处理,少数需额外干预以确保安全结局。

核心结论

  • 抗反流与食管裂孔疝手术安全,死亡罕见,发病率适中;多数并发症为轻微(CD<3a)且易处理,少数发生需额外干预的严重并发症(CD 3a或以上)。

研究设计与样本

  • 单中心回顾性研究,纳入2003年至2020年2342例抗反流与食管裂孔疝手术病例,评估术中并发症所致术后后遗症及90天内发病率与死亡率,所有并发症按Clavien-Dindo分级,每例患者在30天和31至90天区间取最高并发症等级。

主要发现

  • 30天总发病率为18.2%(427/2342),死亡率为0.2%(4/2342);CD<3a并发症占13.1%(306/2342)。
  • 31至90天发病率降至3.1%(78/2338),死亡率降至0.09%(2/2338);CD<3a并发症占1.9%(42/2338)。

关键数值与推荐

  • 30天总发病率18.2%(427/2342),死亡率0.2%(4/2342),CD<3a并发症13.1%(306/2342)。
  • 31至90天发病率3.1%(78/2338),死亡率0.09%(2/2338),CD<3a并发症1.9%(42/2338)。

临床怎么用

  • 作者认为这些数据有助于告知患者手术风险并指导医生进行最佳知情同意。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The historic morbidity and mortality rates of antireflux and hiatal hernia operation are reported as 3% to 21% and 0.2% to 0.5%, respectively. These data come from either large national and population level or small institutional studies, with the former focusing on broad 30-day outcomes while lacking granular data on complications and their severity. Institutional studies tend to focus on long-term and quality-of-life outcomes. Our objective is to describe and evaluate the incidence of 30- and 90-day morbidity and mortality in a large, single-institution dataset. STUDY DESIGN: We retrospectively reviewed 2,342 cases of antireflux and hiatal hernia operation from 2003 to 2020 for intraoperative complications causing postoperative sequelae, as well as morbidity and mortality within 90 days. All complications were graded using the Clavien-Dindo (CD) grading system. The highest grade of complication was used per patient during 30- and 31- to 90-day intervals. RESULTS: Of 2,342 patients, the overall 30-day morbidity and mortality rates were 18.2% (427 of 2,342) and 0.2% (4 of 2,342), respectively. Most of the complications were CD less than 3a at 13.1% (306 of 2,342). In the 31- to 90-day postoperative period, morbidity and mortality rates decreased to 3.1% (78 of 2,338) and 0.09% (2 of 2,338). CD less than 3a complications accounted for 1.9% (42 of 2,338). CONCLUSIONS: Antireflux and hiatal hernia operations are safe with rare mortality and modest rates of morbidity. However, the majority of complications patients experience are minor (CD less than 3a) and are easily managed. A minority of patients will experience major complications (CD 3a or greater) that require additional procedures and management to secure a safe outcome. These data are helpful to inform patients of the risks of operation and guide physicians for optimal consent.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Ivy ML, Baison G, Griffin C, et al. Thirty- and 90-Day Morbidity and Mortality by Clavien-Dindo after Surgery for Antireflux and Hiatal Hernia. J Am Coll Surg. 2024. PMID: 38717030. doi:10.1097/XCS.0000000000001114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。